Series 41 High Flow Low Pressure Reducing Regulator | Equilibar

Series 41 High Flow Low Pressure Reducing Regulator

Port Sizes:
3/8"1/2"3/4"
Typical Pressure Ranges:
0 - 0.7 psi0 - 1.4 psi0 - 3 psi0 - 5 psi
Key Applications:
  • High Accuracy
  • Superior Sensitivity
  • Light Weight
  • Compact Size
Product Description
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

The Series 41 is a pressure reducing regulator designed to control low pressures at flow rates from static through high flow
The series 41 is a no-bleed design regulator that does not consume air in the steady state.
FEATURES
• Sensitive to 0.05 inches of water column
• High forward flow capacity
• High flow exhaust/vent
• Low pressure droop under flow

 

The Equilibar Series 41 is a manually adjustable spring-operated pressure reducing regulator. The spring force is manually set using the adjustment knob. The spring acts on the top of the diaphragm assembly to open the main internal valve which allows the compressed gas supply to flow into the system and increase the system pressure.

Videos
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

Downloads
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

Applications
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

  • High Accuracy
  • Superior Sensitivity
  • Light Weight
  • Compact Size
Additional Specs
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

Weight:

5.0 lbs (2.27 kg)

Dimensions:

Fitting/Threads:

Standard: NPT
Optional: BSPT

How It Works
Series 41 High Flow Low Pressure Reducing Regulator

Series 41 High Flow Low Pressure Reducing Regulator

Related Products

Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More